Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
fda
4
×
indiana blog main
indiana top stories
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
4
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
bristol-myers squibb
cancer
clinical trials
deals
generic drugs
ipo
lasmiditan
shire
startups
takeda pharmaceutical
What
pharmaceutical
4
×
bio
roundup
drugs
eli
giant
new
acute
addresses
american
appetite
approval
bails
based
best
black
brand
bread
bridgebio
butter
buyout
cancer
capital
car
cash
causes
condition
continue
crash
debate
decades
develop
diabetes
diamond’s
drug
emerges
fda
firm
friday
giving
Language
unset
Current search:
fda
×
biotech
×
" raleigh-durham top stories "
×
pharmaceutical
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More